Atossa Therapeutics News, Atossa Therapeutics Quote, ATOS Quote

Atossa Therapeutics (NQ:ATOS) Delayed: 2.41 -0.13 (5.12%)

Prev. Close

$2.54

Today 6M 1Y 5Y

Open

$2.53

52 Wk High

$3.64

52 Wk Low

$0.14

Day High

$2.56

Day Low

$2.38

P/E

N/A

EPS

$0.00

Volume

139,575

Friends, Peers and Foes (?): AEXAY, ATO, A1SN34, ASND, ONCY (more...)

ALERTS | RSS

Oct 19, 2026 08:04 AM Atossa Therapeutics attaches CVRs to each share of common stock
Oct 19, 2026 08:00 AM Atossa Therapeutics Common Stock to Begin Trading with Stapled Contingent Value Rights After Close of Business Today
Oct 9, 2026 08:15 AM Form 8-K ATOSSA THERAPEUTICS, For: Oct 08
Oct 9, 2026 08:01 AM Atossa Therapeutics sets CVR plan tied to potential FDA voucher
Oct 9, 2026 08:00 AM Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation in Potential Priority Review Voucher Value
Sep 29, 2026 08:02 AM Atossa Therapeutics plans CVR tied to rare pediatric voucher
Sep 29, 2026 08:01 AM Atossa Therapeutics Announces Plan to Issue Stapled CVR for Shareholders Tied to Potential Rare Pediatric Disease Priority Review Voucher
Sep 29, 2026 08:00 AM Form 8-K ATOSSA THERAPEUTICS, For: Sep 29
Sep 24, 2026 08:00 AM Atossa Therapeutics CEO Dr. Steven Quay to Participate in ARDD 2026 Panel on Clinical Trials and Regulatory Pathways for Diseases of Aging
Sep 18, 2026 05:00 PM Form 8-K ATOSSA THERAPEUTICS, For: Sep 18

Entities mentioned with ATOS

View All Entities